265 related articles for article (PubMed ID: 26675378)
41. NAD
Moore AM; Zhou L; Cui J; Li L; Wu N; Yu A; Poddar S; Liang K; Abt ER; Kim S; Ghukasyan R; Khachatourian N; Pagano K; Elliott I; Dann AM; Riahi R; Le T; Dawson DW; Radu CG; Donahue TR
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33597293
[TBL] [Abstract][Full Text] [Related]
42. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
Hasmann M; Schemainda I
Cancer Res; 2003 Nov; 63(21):7436-42. PubMed ID: 14612543
[TBL] [Abstract][Full Text] [Related]
43. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.
Grozio A; Sociali G; Sturla L; Caffa I; Soncini D; Salis A; Raffaelli N; De Flora A; Nencioni A; Bruzzone S
J Biol Chem; 2013 Sep; 288(36):25938-25949. PubMed ID: 23880765
[TBL] [Abstract][Full Text] [Related]
44. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation.
Managò A; Audrito V; Mazzola F; Sorci L; Gaudino F; Gizzi K; Vitale N; Incarnato D; Minazzato G; Ianniello A; Varriale A; D'Auria S; Mengozzi G; Politano G; Oliviero S; Raffaelli N; Deaglio S
Nat Commun; 2019 Sep; 10(1):4116. PubMed ID: 31511522
[TBL] [Abstract][Full Text] [Related]
45. Targeting the NAD
Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
[TBL] [Abstract][Full Text] [Related]
46. Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy.
Galli U; Colombo G; Travelli C; Tron GC; Genazzani AA; Grolla AA
Front Pharmacol; 2020; 11():656. PubMed ID: 32477131
[TBL] [Abstract][Full Text] [Related]
47. NAMPT is the cellular target of STF-31-like small-molecule probes.
Adams DJ; Ito D; Rees MG; Seashore-Ludlow B; Puyang X; Ramos AH; Cheah JH; Clemons PA; Warmuth M; Zhu P; Shamji AF; Schreiber SL
ACS Chem Biol; 2014 Oct; 9(10):2247-54. PubMed ID: 25058389
[TBL] [Abstract][Full Text] [Related]
48. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells.
Revollo JR; Grimm AA; Imai S
J Biol Chem; 2004 Dec; 279(49):50754-63. PubMed ID: 15381699
[TBL] [Abstract][Full Text] [Related]
49. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters.
Zhang T; Berrocal JG; Frizzell KM; Gamble MJ; DuMond ME; Krishnakumar R; Yang T; Sauve AA; Kraus WL
J Biol Chem; 2009 Jul; 284(30):20408-17. PubMed ID: 19478080
[TBL] [Abstract][Full Text] [Related]
50. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
Sociali G; Grozio A; Caffa I; Schuster S; Becherini P; Damonte P; Sturla L; Fresia C; Passalacqua M; Mazzola F; Raffaelli N; Garten A; Kiess W; Cea M; Nencioni A; Bruzzone S
FASEB J; 2019 Mar; 33(3):3704-3717. PubMed ID: 30514106
[TBL] [Abstract][Full Text] [Related]
51. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
Hsu CP; Oka S; Shao D; Hariharan N; Sadoshima J
Circ Res; 2009 Aug; 105(5):481-91. PubMed ID: 19661458
[TBL] [Abstract][Full Text] [Related]
52. MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD.
Alizadeh-Fanalou S; Hosseinkhani S; Nazarizadeh A; Ezzati-Mobaser S; Hesari Z; Aziminezhadan P; Abdolvahabi Z; Abolmaali M; Tavakoli-Yaraki M; Nourbakhsh M
DNA Cell Biol; 2021 Jul; 40(7):1026-1036. PubMed ID: 34101492
[TBL] [Abstract][Full Text] [Related]
53. Both gain and loss of Nampt function promote pressure overload-induced heart failure.
Byun J; Oka SI; Imai N; Huang CY; Ralda G; Zhai P; Ikeda Y; Ikeda S; Sadoshima J
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H711-H725. PubMed ID: 31347918
[TBL] [Abstract][Full Text] [Related]
54. Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma.
Davis K; Dunseth CD; Mott SL; Cramer-Morales KL; Miller AM; Ear PH; Mezhir JJ; Bellizzi AM; Chan CHF
PLoS One; 2019; 14(3):e0213576. PubMed ID: 30856230
[TBL] [Abstract][Full Text] [Related]
55.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
56. Nampt: linking NAD biology, metabolism and cancer.
Garten A; Petzold S; Körner A; Imai S; Kiess W
Trends Endocrinol Metab; 2009 Apr; 20(3):130-8. PubMed ID: 19109034
[TBL] [Abstract][Full Text] [Related]
57. Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy.
Bobbert P; Kühl U; Poller W; Rauch U; Schultheiss HP; Skurk C
J Card Fail; 2015 Apr; 21(4):330-8. PubMed ID: 25498756
[TBL] [Abstract][Full Text] [Related]
58. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Xiao Y; Elkins K; Durieux JK; Lee L; Oeh J; Yang LX; Liang X; DelNagro C; Tremayne J; Kwong M; Liederer BM; Jackson PK; Belmont LD; Sampath D; O'Brien T
Neoplasia; 2013 Oct; 15(10):1151-60. PubMed ID: 24204194
[TBL] [Abstract][Full Text] [Related]
59. Nicotinamide Phosphoribosyltransferase in Smooth Muscle Cells Maintains Genome Integrity, Resists Aortic Medial Degeneration, and Is Suppressed in Human Thoracic Aortic Aneurysm Disease.
Watson A; Nong Z; Yin H; O'Neil C; Fox S; Balint B; Guo L; Leo O; Chu MWA; Gros R; Pickering JG
Circ Res; 2017 Jun; 120(12):1889-1902. PubMed ID: 28356339
[TBL] [Abstract][Full Text] [Related]
60. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
